Physician profile
Michael A Conway
NPI 1043392582
$2,018.46
in general payments reported to CMS, 2019-2025
12 companies · $835 in 2025
The $835 reported for 2025 was more than what 76% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2021: $90.03 · 2022: $85.47 · 2023: $194 · 2024: $648 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,677.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $379.78 | 2021-2025 | Grafix Pl, Oasis, Grafix |
| Abbott Laboratories | $270.88 | 2024-2025 | Supera, Esprit |
| Bioventus LLC | $255.59 | 2023-2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $220.90 | 2024-2025 | Nuzyra |
| Kerecis Limited | $187.36 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medtronic Vascular, INC. | $153.08 | 2019 | |
| Amgen INC. | $125.00 | 2025 | Krystexxa |
| Averitas Pharma INC. | $122.19 | 2024 | Qutenza |
| Stryker Corporation | $105.72 | 2025 | Flexband, Citrefix |
| Biocomposites INC | $100.00 | 2025 | Stimulan |
| Stability Biologics, LLC | $85.47 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.